Table 4.
Triose phosphate isomerase (1AMK) 1AMK – E.C.5.3.1.1 | Pyruvate kinase – domain 2 (4DRS) E.C.2.7.1.40 – absent in domain 2 | ||||
---|---|---|---|---|---|
Fragment | Characteristics | RD | Fragment | Characteristics | RD |
Protein | 250 | 0.506 | Protein | 248 | 0.559 |
6–12 B | E 11 N, 13 K, | 0.401 | 47–52 B | 0.330 | |
17–30 H | 0.402 | 53–57 H | 0.278 | ||
38–42 B | 0.452 | 58–69 H | 0.475 | ||
44–47 H | 0.747 | 71–77 B | 0.497 | ||
48–55 H | 0.336 | 81–98 H | 0.432 | ||
59–63 B | 0.263 | 105–110 B | 0.580 | ||
79–86 H | 0.330 | 214–224 H | 0.404 | ||
89–93 B | 0.148 | 231–235 B | 0.378 | ||
95–102 H | E 95H | 0.634 | 240–253 H | 0.387 | |
105–119 H | 0.366 | 266–271 B | 0.477 | ||
122–127 B | 0.321 | 273–279 H | 0.551 | ||
130–136 H | 0.541 | 280–287 H | 0.329 | ||
138–152 H | 0.364 | 289–294 B | 0.390 | ||
153–154 H | 0.319 | 296–301 H | 0.647 | ||
155–160 H | 0.340 | 302–305 H | 0.534 | ||
161–167 B | E 167E | 0.317 | 306–321 H | 0.569 | |
168–172 H | 0.571 | 323–327 B | 0.395 | ||
179–198 H | E 173G | 0.423 | 331–336 H | 0.440 | |
199–206 H | 0.654 | 341–355 H | 0.418 | ||
207–212 B | 0.542 | 357–361 B | 0.306 | ||
218–224 H | 0.382 | 362–367 H | 0.603 | ||
229–233 B | 0.524 | 370–387 H | 0.553 | ||
234–239 H | 0.222 | ||||
240–241 H | 0.600 | ||||
242–248 H | 0.160 | ||||
Β-sheet | β-sheet | 0.429 | |||
Helices | Helices | 0.482 | |||
Eliminated | 95–100,198–203 | 0.479 | No ligand | 0.546 | |
No ligand | 0.498 | No residues | 74–80 L, 229–236 L, 259–262, 264–272 L, 293–296, 319–321 L | 0.486 | |
NoE | 11,13,95,167,173 | 0.500 |
Values listed in boldface satisfy RD > 0.5. “B” and “H” stand for β- and helical forms respectively; “L” indicates a ligand-binding fragment while “E” denotes that the given fragment contains an enzymatically active residue (listing its number and type). The row labeled “NoE” represents the status of each domain following elimination of catalytic residues — the observed reduction in RD values indicates that catalytic residues diverge from the theoretical model.